3
Announcements
Trials
Browse
Landscape
Sponsor
Conditions
Breast Neoplasms
6
Triple Negative Breast Neoplasms
3
Urinary Bladder Neoplasms
2
Neoplasm Metastasis
2
Urethral Neoplasms
1
Ureteral Neoplasms
1
Refractory Solid Tumors
1
Carcinoma, Transitional Cell
1
Interventions
Temozolomide
4
Cyclophosphamide
4
X-Rays
3
Vincristine
3
Specimen Handling
3
Phantoms, Imaging
3
Magnetic Resonance Spectroscopy
3
Ifosfamide
3
Etoposide
3
Doxorubicin
3
ulixertinib
2
tipifarnib
2
selpercatinib
2
ivosidenib
2
cabozantinib
2
Topotecan
2
Radiation
2
Nuclear Medicine Department, Hospital
2
Irinotecan
2
Congresses as Topic
2
trifluridine tipiracil drug combination
1
tazemetostat
1
talazoparib
1
palbociclib
1
olaparib
1
liposomal doxorubicin
1
larotrectinib
1
irinotecan sucrosofate
1
ganitumab
1
fludarabine phosphate
1
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
0 trials
Recent
Start date
Enrollment
Sarcoma, Ewing
×
eribulin
×
30 days
×
Clear all
No trials found.